Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

5.1K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Nucleolus02:55

The Nucleolus

9.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Destabilization of Microtubules01:45

Destabilization of Microtubules

2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 腫瘍学とがん発生
  9. 分子標的
  11. ダイノルフィンaは,sp-1を増加させることで,骨髄腫細胞のミトコンドリア生殖を阻害する.

ダイノルフィンAは,SP-1を増加させることで,骨髄腫細胞のミトコンドリア生殖を阻害する.

Yaxiong Dai1, Jian Zhang2, Yingzhen Peng3

  • 1Department of Orthopedics, Huanggang Central Hospital of Yangtze University, Huanggang, China.

Journal of biochemical and molecular toxicology
|August 21, 2025

関連する実験動画

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.2K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

PubMed で要約を見る

まとめ
この要約は機械生成です。

ダイノルフィンAは,ミトコンドリア機能とバイオゲネシスを妨害することで,骨肉腫細胞の生存能力を低下させます. このペプチド誘発の細胞毒性は,エネルギー生産の低下とミトコンドリアの成長の抑制を含み,骨髄腫 (OS) の潜在的な治療戦略を提供します.

科学分野:

  • ミトコンドリア生物学
  • 癌の研究
  • 薬理学について

背景:

  • ミトコンドリアは細胞のエネルギーと代謝に不可欠であり,特に骨髄腫 (OS) の治療において重要な標的となっています.
  • ダイノルフィンAは抗腫瘍特性を示しているが,骨肉肉腫のミトコンドリア生理学に対する特異的な影響は,大部分未調査のままである.

研究 の 目的:

  • ヒトの骨肉腫 (U2OS) 細胞におけるミトコンドリア機能と生体生成に対するダイノルフィンAの影響を調査する.
  • 骨肉腫におけるダイノルフィンAの潜在的な抗癌効果の基礎となる分子メカニズムを解明する.

主な方法:

  • ヒトの骨肉腫U2OS細胞は,ダイノルフィンAで治療されました.
  • 細胞活性,細胞毒性 (LDH検査),ミトコンドリア機能 (複合IV活性,OCR,ATP生成),ミトコンドリア生殖 (mtDNA/nDNA比,タンパク質発現,ミトコンドリア質量) を評価した.
  • ミトコンドリアのレギュレータ (PGC-1α,Nrf1,TFAM) とSP-1の定量表現はRT-PCRとウエスタンブロットを用いて;SP-1は,その役割を評価するために沈黙させられた.

主要な成果:

  • 細胞活性が低下し,LDHの放出が増加し,細胞毒性を示した.
  • 複合体IVの活動,酸素の消費,ATPの生成が低下した.
  • ディノルフィンAはミトコンドリア生殖を抑制し,ミトコンドリアのmtDNA/ nDNA比率が低下し,ミトコンドリアのタンパク質発現が低下し,ミトコンドリアの質量が減少した.
キーワード:
ダイノルフィンAPGC-1αについてSP-1 について

関連する実験動画

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.2K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K
  • PGC-1α,Nrf1,TFAMのダウンレギュレーションとSP-1のアップレギュレーションが認められた. ミトコンドリア機能と生体形成への影響を逆転させた.

    • 結論:

    • ダイノルフィンAは,ミトコンドリア機能と生体形成を著しく妨害することで,骨肉腫細胞に抗腫瘍効果を発揮する.
    • 観察された効果は,少なくとも部分的には,SP- 1の発現の調節によって媒介され,SP- 1がDynorphin Aの作用メカニズムに重要な役割を果たしていることを示唆しています.
    • これらの発見は,がん治療のためのミトコンドリア経路を標的とした骨肉腫の潜在的な治療薬としてダイノルフィンAを強調しています.
    ミトコンドリアの生体生成
    オステオサルコマ